4/17
08:02 pm
evax
Evaxion's AI-Immunology™ platform demonstrates 86% vaccine target precision in phase 2 personalized cancer vaccine trial [Yahoo! Finance]
Medium
Report
Evaxion's AI-Immunology™ platform demonstrates 86% vaccine target precision in phase 2 personalized cancer vaccine trial [Yahoo! Finance]
4/17
03:10 pm
evax
Evaxion’s AI-Immunology™ platform demonstrates 86% vaccine target precision in phase 2 personalized cancer vaccine trial
Low
Report
Evaxion’s AI-Immunology™ platform demonstrates 86% vaccine target precision in phase 2 personalized cancer vaccine trial
4/17
03:00 pm
evax
New data demonstrates the unique scalability of Evaxion’s AI-Immunology™ platform in glioblastoma
Medium
Report
New data demonstrates the unique scalability of Evaxion’s AI-Immunology™ platform in glioblastoma
4/16
11:30 am
evax
Evaxion concludes Annual General Meeting
Low
Report
Evaxion concludes Annual General Meeting
4/7
08:00 am
evax
Evaxion announces last patient visit in one-year extension of phase 2 trial with personalized cancer vaccine EVX-01
Medium
Report
Evaxion announces last patient visit in one-year extension of phase 2 trial with personalized cancer vaccine EVX-01
3/30
08:13 am
evax
Evaxion to present novel AI-based polio vaccine design concepts at the World Vaccine Congress [Yahoo! Finance]
Medium
Report
Evaxion to present novel AI-based polio vaccine design concepts at the World Vaccine Congress [Yahoo! Finance]
3/30
08:00 am
evax
Evaxion to present novel AI-based polio vaccine design concepts at the World Vaccine Congress
Medium
Report
Evaxion to present novel AI-based polio vaccine design concepts at the World Vaccine Congress
3/22
01:04 am
evax
Low
Report
3/19
09:00 am
evax
Notice to convene Evaxion’s Annual General Meeting
Medium
Report
Notice to convene Evaxion’s Annual General Meeting
3/17
05:14 pm
evax
Evaxion to present new data at AACR Annual Meeting [Yahoo! Finance]
Low
Report
Evaxion to present new data at AACR Annual Meeting [Yahoo! Finance]
3/17
04:30 pm
evax
Evaxion to present new data at AACR Annual Meeting
Low
Report
Evaxion to present new data at AACR Annual Meeting
3/14
01:32 am
evax
High
Report
3/10
01:01 pm
evax
Evaxion A/S (EVAX) is now covered by JonesTrading. They set a "buy" rating and a $10.00 price target on the stock.
Low
Report
Evaxion A/S (EVAX) is now covered by JonesTrading. They set a "buy" rating and a $10.00 price target on the stock.
3/9
01:24 pm
evax
Evaxion A/S (EVAX) had its price target lowered by Lake Street Capital from $11.00 to $9.00. They now have a "buy" rating on the stock.
Low
Report
Evaxion A/S (EVAX) had its price target lowered by Lake Street Capital from $11.00 to $9.00. They now have a "buy" rating on the stock.
3/9
08:03 am
evax
Evaxion A/S (EVAX) had its "buy" rating reaffirmed by HC Wainwright. They now have a $16.00 price target on the stock.
Neutral
Report
Evaxion A/S (EVAX) had its "buy" rating reaffirmed by HC Wainwright. They now have a $16.00 price target on the stock.
3/5
09:28 am
evax
Evaxion announces business update and full year 2025 financial results
Medium
Report
Evaxion announces business update and full year 2025 financial results
3/5
08:02 am
evax
Evaxion plans to file 2025 annual report later today
Medium
Report
Evaxion plans to file 2025 annual report later today
3/2
08:00 am
evax
Evaxion to announce business update and full year 2025 financial results on March 5, 2026
Low
Report
Evaxion to announce business update and full year 2025 financial results on March 5, 2026
2/19
09:00 am
evax
Evaxion A/S (NASDAQ:EVAX) is now covered by analysts at Maxim Group. They set a "buy" rating and a $10.00 price target on the stock.
Medium
Report
Evaxion A/S (NASDAQ:EVAX) is now covered by analysts at Maxim Group. They set a "buy" rating and a $10.00 price target on the stock.